NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Health Business Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Acucela Inc.



Acucela to Present at the Rodman & Renshaw Healthcare Conference



November 28th, 2008

Acucela Inc., a clinical-stage biotechnology company focused on developing therapies for blinding eye diseases, announced that Ryo Kubota, M.D., Ph.D., Acucela's chief executive officer, will present a company update at the Rodman & Renshaw 10th Annual Healthcare Conference. The presentation is scheduled for 10:20 a.m. EST on Wednesday, November 12, 2008 at the New York Palace Hotel in New York City.

"We are excited to have the opportunity to present an overview of Acucela at the Rodman & Renshaw Healthcare Conference," stated Dr. Kubota. "We at Acucela are sharply focused on developing new drug therapies for blinding eye diseases, and we look forward to discussing our...


Source: Health Business Week (2008-11-28)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login